Sigma Planning Corp’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-10,240
Closed -$262K 1025
2018
Q2
$262K Buy
10,240
+295
+3% +$6.88K 0.02% 709
2018
Q1
$200K Sell
9,945
-1,730
-15% -$40.4K 0.01% 783
2017
Q4
$234K Sell
11,675
-252
-2% -$4.96K 0.02% 710
2017
Q3
$247K Sell
11,927
-1,997
-14% -$33.8K 0.02% 685
2017
Q2
$206K Buy
13,924
+1,250
+10% +$20.8K 0.02% 700
2017
Q1
$202K Sell
12,674
-2,991
-19% -$43.1K 0.02% 701
2016
Q4
$197K Sell
15,665
-3,096
-17% -$57.7K 0.02% 650
2016
Q3
$525K Buy
18,761
+55
+0.3% +$1.85K 0.06% 328
2016
Q2
$655K Sell
18,706
-2,115
-10% -$66.5K 0.09% 264
2016
Q1
$570K Sell
20,821
-16,680
-44% -$491K 0.08% 284
2015
Q4
$1.28M Buy
37,501
+9,277
+33% +$289K 0.18% 132
2015
Q3
$811K Buy
28,224
+1,619
+6% +$69.2K 0.13% 193
2015
Q2
$1.19M Buy
+26,605
New +$1M 0.16% 153

Other funds holding DPLO

Sigma Planning Corp's DPLO Position: Q3 2018 in Review

Sigma Planning Corp sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 10,240 shares — an estimated $262K sold.

Sigma Planning Corp first reported a position in DPLO in Q2 2015 and held it in 13 quarters. The position peaked at $1.28M in Q4 2015. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

  • Sigma Planning Corp reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
  • Sigma Planning Corp sold 10,240 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $262K.
  • Sigma Planning Corp first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 13 quarters.
  • Sigma Planning Corp's DIPLOMAT PHARMACY, INC. position peaked at $1.28M in Q4 2015.
  • 178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Sigma Planning Corp's 13F filing for Q3 2018, filed 7 Nov 2018.